2,3-butylene glycol has been researched along with Kidney Failure, Chronic in 1 studies
2,3-butylene glycol: RN given refers to cpd without isomeric designation
butane-2,3-diol : A butanediol in which hydroxylation is at C-2 and C-3.
Kidney Failure, Chronic: The end-stage of CHRONIC RENAL INSUFFICIENCY. It is characterized by the severe irreversible kidney damage (as measured by the level of PROTEINURIA) and the reduction in GLOMERULAR FILTRATION RATE to less than 15 ml per min (Kidney Foundation: Kidney Disease Outcome Quality Initiative, 2002). These patients generally require HEMODIALYSIS or KIDNEY TRANSPLANTATION.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Heierli, C | 1 |
| Thölen, H | 1 |
1 other study available for 2,3-butylene glycol and Kidney Failure, Chronic
| Article | Year |
|---|---|
Metabolites of glucose in the blood of patients with renal failure.
Topics: 2,3-Diphosphoglycerate; Acetaldehyde; Acetates; Acetoin; Adult; Aged; Blood Glucose; Butylene Glycol | 1981 |